Mr. Joshua Bartch reports

MINDLEAP HEALTH SIGNS AGREEMENT WITH BRIGHTMIND TO LAUNCH COMPREHENSIVE MEDITATION PROGRAM

Mydecine Innovations Group Inc.'s subsidiary Mindleap Health Inc. has signed an agreement dated July 21, 2020, with Brightmind to launch a comprehensive meditation program on Mindleap's advanced digital health platform. Under the terms of the agreement, Brightmind will provide specialized meditation content to Mindleap, and Mindleap will make that content available for purchase on the platform.

Brightmind is a leading meditation app that provides customized and practical instruction by world-class meditation experts. Brightmind offers a robust curriculum that is based on an approach to teaching developed over the past 40 years by the esteemed meditation educator Shinzen Young.

Brightmind is the first and only app that makes Mr. Young's powerful system easily available. The Brightmind app has been downloaded over 100,000 times and has been featured by Apple in its coveted "New Apps We Love" section, as well as Forbes and Huffington Post. Mr. Young's system is so clear and well organized that neuroscience researchers at Harvard and other top universities use his system to design their experiments and have brought Mr. Young on as a research consultant.

Mindleap founder and chief executive officer Nikolai Vassev commented: "Our vision is for a world where people can make lasting life changes by having advanced tools and access to expert mental health professionals right from the palm of their hand. Mindfulness can have numerous benefits, everything from decreased stress and sadness to increased levels of happiness and focus. Brightmind's programs have provided radical transformations for thousands of people, and the partnership with Mindleap should lead to more value for our customers and platform."

Over the past 20 years, meditation and mindfulness-based programs have become increasingly popular. Doctors and mental health professionals are embracing meditation because scientific studies are beginning to show that it works, particularly for stress-related conditions.

The market for meditation apps has exploded into the mainstream and shows little sign of slowing down. In 2019 alone, the meditation market reached $1.2-billion (U.S.). Employers are embracing mindfulness training, and leading apps like Headspace and Calm are reaching over 50 million downloads while commanding billion-dollar valuations. The major players offer relatively simple and shallow meditation instruction, which their users quickly exhaust, while Brightmind's comprehensive and proven programs offer a much more robust value to end-users.

Meditation, when practised and contextualized well, is one of the most effective methods for improving mental health.

Brightmind founder and chief executive officer Toby Sola commented: "Meditation is a way to upgrade our mental software to meet the demands of our rapidly changing world. We have been hard at work to deliver exceptional programs and are thrilled to collaborate with Mindleap so we can deliver our programs to even more people."

The Brightmind meditation program will be a part of five other digital health programs that will be offered on Mindleap later this fall. The scalability, consistency and reduced costs to end-users create a more comprehensive and versatile offering for the Mindleap platform.

About Mydecine Innovations Group Inc.

Mydecine is a life science company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. Mydecine's experienced cross-functional dynamic team has the capability to oversee all areas of drug development, including synthesis, drug delivery system development and clinical trial execution, through to product commercialization and marketing. By leveraging strategic partnerships with scientific, medical, military and clinical organizations, Mydecine is at the forefront of the efficient development of psychedelic-derived medicines and therapeutic solutions. Its trail-blazing portfolio of companies is focused on providing innovative and effective treatment options that can help millions of people live healthier lives.